{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:19:43Z","timestamp":1786119583879,"version":"build-2736575974"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1097\/mnm.0b013e32833d82e6","type":"journal-article","created":{"date-parts":[[2010,8,17]],"date-time":"2010-08-17T09:09:46Z","timestamp":1282036186000},"page":"874-880","source":"Crossref","is-referenced-by-count":19,"title":["Reduction in coronary and peripheral vasomotor function in patients with HIV after initiation of antiretroviral therapy: a longitudinal study with positron emission tomography and flow-mediated dilation"],"prefix":"10.1097","volume":"31","author":[{"given":"Ulrik Sloth","family":"Kristoffersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"Wiinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus Leth","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Gerstoft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Gutte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Mette","family":"Lebech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Kjaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210212","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMoa030218","article-title":"Combination antiretroviral therapy and the risk of myocardial infarction","volume":"349","author":"Friis-Moller","year":"2003","journal-title":"N Engl J Med"},{"key":"R2-6-20210212","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/S0140-6736(02)11672-2","article-title":"Protease inhibitors and cardiovascular outcomes in patients with HIV-1","volume":"360","author":"Holmberg","year":"2002","journal-title":"Lancet"},{"key":"R3-6-20210212","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1097\/00002030-200311210-00010","article-title":"Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men","volume":"17","author":"Mary-Krause","year":"2003","journal-title":"AIDS"},{"key":"R4-6-20210212","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1086\/518285","article-title":"Ischemic heart disease in HIV-infected and HIV-uninfected individuals: a population-based cohort study","volume":"44","author":"Obel","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R5-6-20210212","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1056\/NEJMoa062360","article-title":"Rappoport, CD4+ count-guided interruption of antiretroviral treatment","volume":"355","author":"El Sadr","year":"2006","journal-title":"N Engl J Med"},{"key":"R6-6-20210212","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0735-1097(90)90584-C","article-title":"Large coronary arteries in humans are responsive to changing blood flow: an endothelium-dependent mechanism that fails in patients with atherosclerosis","volume":"16","author":"Nabel","year":"1990","journal-title":"J Am Coll Cardiol"},{"key":"R7-6-20210212","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1161\/01.CIR.83.5.1519","article-title":"Intracoronary thrombus formation causes focal vasoconstriction of epicardial arteries in patients with coronary artery disease","volume":"83","author":"Zeiher","year":"1991","journal-title":"Circulation"},{"key":"R8-6-20210212","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/hrt.74.3.247","article-title":"Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility","volume":"74","author":"Sorensen","year":"1995","journal-title":"Br Heart J"},{"key":"R9-6-20210212","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/0735-1097(95)00359-2","article-title":"Noninvasive quantification of regional myocardial flow reserve in patients with coronary atherosclerosis using nitrogen-13 ammonia positron emission tomography. Determination of extent of altered vascular reactivity","volume":"26","author":"Beanlands","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"R10-6-20210212","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1161\/01.CIR.79.4.825","article-title":"Assessment of coronary artery disease severity by positron emission tomography. Comparison with quantitative arteriography in 193 patients","volume":"79","author":"Demer","year":"1989","journal-title":"Circulation"},{"key":"R11-6-20210212","first-page":"19","article-title":"Dipyridamole, cold pressor test, and demonstration of endothelial dysfunction: a PET study of myocardial perfusion in diabetes","volume":"44","author":"Kjaer","year":"2003","journal-title":"J Nucl Med"},{"key":"R12-6-20210212","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1016\/j.amjcard.2005.07.090","article-title":"Positron emission tomographic evaluation of regulation of myocardial perfusion in physiological (elite athletes) and pathological (systemic hypertension) left ventricular hypertrophy","volume":"96","author":"Kjaer","year":"2005","journal-title":"Am J Cardiol"},{"key":"R13-6-20210212","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0735-1097(01)01746-6","article-title":"Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force","volume":"39","author":"Corretti","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"R14-6-20210212","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/jac\/dkl190","article-title":"Endothelial function in HIV-infected patients with low or mild cardiovascular risk","volume":"58","author":"Blanco","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"R15-6-20210212","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1161\/CIRCULATIONAHA.104.517144","article-title":"Early structural and functional changes of the vasculature in HIV-infected children: impact of disease and antiretroviral therapy","volume":"112","author":"Charakida","year":"2005","journal-title":"Circulation"},{"key":"R16-6-20210212","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s12012-007-9010-y","article-title":"Severe impairment of endothelial function with the HIV-1 protease inhibitor indinavir is not mediated by insulin resistance in healthy subjects","volume":"8","author":"Dube","year":"2008","journal-title":"Cardiovasc Toxicol"},{"key":"R17-6-20210212","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1097\/QAD.0b013e32832e7140","article-title":"Association of abacavir and impaired endothelial function in treated and suppressed HIV-infected patients","volume":"23","author":"Hsue","year":"2009","journal-title":"AIDS"},{"key":"R18-6-20210212","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/01.qai.0000228790.40235.0c","article-title":"Antiretrovirals induce direct endothelial dysfunction in vivo","volume":"42","author":"Jiang","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R19-6-20210212","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.ahj.2005.06.005","article-title":"Indinavir impairs endothelial function in healthy HIV-negative men","volume":"150","author":"Shankar","year":"2005","journal-title":"Am Heart J"},{"key":"R20-6-20210212","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1161\/01.CIR.104.3.257","article-title":"Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction","volume":"104","author":"Stein","year":"2001","journal-title":"Circulation"},{"key":"R21-6-20210212","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jacc.2008.04.049","article-title":"Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: The ACTG (AIDS Clinical Trials Group) Study 5152s","volume":"52","author":"Torriani","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R22-6-20210212","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000129064","article-title":"Advanced age is associated with endothelial dysfunction in healthy elderly subjects","volume":"54","author":"Yavuz","year":"2008","journal-title":"Gerontology"},{"key":"R23-6-20210212","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/PSY.0b013e3181cdbfc0","article-title":"Adverse impact of mood on flow-mediated dilation","volume":"72","author":"Cooper","year":"2010","journal-title":"Psychosom Med"},{"key":"R24-6-20210212","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1468-1293.2008.00661.x","article-title":"Reduction in circulating markers of endothelial dysfunction in HIV-infected patients during antiretroviral therapy","volume":"10","author":"Kristoffersen","year":"2009","journal-title":"HIV Med"},{"key":"R25-6-20210212","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jacl.2008.08.442","article-title":"Lipoprotein changes in HIV-infected antiretroviral-naive individuals after starting antiretroviral therapy: ACTG Study A5152s Stein: lipoprotein changes on antiretroviral therapy","volume":"2","author":"Stein","year":"2008","journal-title":"J Clin Lipidol"},{"key":"R26-6-20210212","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1007\/s00259-008-0846-6","article-title":"Coronary and peripheral endothelial function in HIV patients studied with positron emission tomography and flow-mediated dilation: relation to hypercholesterolemia","volume":"35","author":"Lebech","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Nuclear Medicine Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006231-201010000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:35:06Z","timestamp":1786041306000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006231-201010000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/mnm.0b013e32833d82e6","relation":{},"ISSN":["0143-3636"],"issn-type":[{"value":"0143-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}